People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Onfolio Holdings, Inc | — | Other Technology | Series B | $39.4M | $4.7M | 2023 |
| Hypertension Diagnostics Inc /Mn | — | Biotechnology | Pre-Seed | $834K | $46.0M | 2012 |
Mark N. Schwartz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark N. Schwartz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Schwartz | 1 | 5 |
| Andrew Lawrence | 1 | 2 |
| David McKeegan | 1 | 1 |
| Robert Lipstein | 1 | 1 |
| Esbe Van Heerden | 1 | 1 |
| Robert J. Lipstein | 1 | 1 |
| Yury Byalik | 1 | 1 |
| Robertus Te Braake | 1 | 1 |
| Alan N Stern | 1 | 1 |
| Kenneth W Brimmer | 1 | 1 |
| Dominic Wells | 1 | 1 |
| Larry N Leitner | 1 | 1 |
| Adam Trainor | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.